Aizon secures funds to accelerate development pipeline
Pharmaceutical Business Review
FEBRUARY 9, 2024
The investment will also enable the company to enhance the outcomes in pharma manufacturing by scaling its operations and improve customer service. A growth equity fund specialising in pharmaceuticals and biotechnology service businesses, NewVale Capital, led the financing round.
Let's personalize your content